Pfizer Responds to the Coronavirus Pandemic

As the coronavirus disease (COVID-19) continues to spread, at Pfizer, we are committed to ensuring public health and safety for our colleagues, retirees, and global patient community. Learn more about COVID-19 and what you can do to stay safe and prevent the spread of this infectious disease. Please share these resources with your loved ones and friends.

COVID-19 Temporary Benefits Coverage Enhancements for U.S. Retirees

As the concerns and fears of the COVID-19 virus impact our daily lives, Pfizer has reviewed its U.S. medical plans to make it easier and less costly for retirees to receive the medical care, including testing for COVID-19, they may need.

The COVID-19 Pandemic Explained

News of the coronavirus COVID-19 seem to be everywhere. Understandably, there is a lot of uncertainty and anxiety about the pandemic.

Racing to Develop a Potential COVID-19 Vaccine with Unprecedented Partnership

The current global scale of the COVID-19 pandemic requires nothing short of a fast-moving and nimble international effort to thwart it.

Pfizer & BioNTech to Co-Develop Potential COVID-19 Vaccine

Companies will jointly develop BioNTech’s mRNA-based vaccine candidate BNT162 to prevent COVID-19 infection collaboration aims to accelerate global development of BNT162, leveraging expertise and resources of both companies Builds on 2018 agreement to jointly develop an mRNA-based influenza vaccine.

Pfizer Outlines Five-Point Plan to Battle COVID-19

Chairman and CEO Albert Bourla calls on biopharma industry to collaborate on combatting the global pandemic.

Join the Pfizer Plus Community Corner

When you join the community, you can get access to our special “member’s only” features including:

  • Member Only Content
  • Email Updates
  • Community